Related Articles
The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer
Activation of Toll‑like receptor 7 regulates the expression of IFN‑λ1, p53, PTEN, VEGF, TIMP‑1 and MMP‑9 in pancreatic cancer cells
Association between Toll-like receptor 7 Gln11Leu single-nucleotide polymorphism and basal cell carcinoma
TLR7 agonist induced repression of hepatocellular carcinoma via the TLR7-IKK-NF-κB-IL6 signaling pathway
Progress of immune checkpoint therapy in the clinic (Review)